CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade DiaMedica Therapeutics Inc. - DMAC CFD

5.6996
0.71%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0708
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023346 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001124 %
Charges from full value of position ($0.21)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 5.6596
Open 5.1896
1-Year Change 83.18%
Day's Range 5.1696 - 5.8596
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 17, 2025 5.6996 0.3400 6.34% 5.3596 5.9096 5.1496
Jan 16, 2025 5.6596 0.6300 12.53% 5.0296 5.6796 5.0296
Jan 15, 2025 5.3696 0.4000 8.05% 4.9696 5.4596 4.9696
Jan 14, 2025 5.0096 0.1400 2.87% 4.8696 5.0696 4.8696
Jan 13, 2025 4.9296 -0.2100 -4.09% 5.1396 5.1996 4.8796
Jan 10, 2025 5.2196 -0.1200 -2.25% 5.3396 5.3596 5.1396
Jan 8, 2025 5.4496 -0.1100 -1.98% 5.5596 5.5996 5.2696
Jan 7, 2025 5.6896 0.4200 7.97% 5.2696 5.8196 5.2696
Jan 6, 2025 5.4196 -0.2000 -3.56% 5.6196 5.6396 5.2396
Jan 3, 2025 5.5496 0.2400 4.52% 5.3096 5.8296 5.3096
Jan 2, 2025 5.4696 0.2500 4.79% 5.2196 5.5696 5.1896
Dec 31, 2024 5.4096 0.2200 4.24% 5.1896 5.4696 5.1896
Dec 30, 2024 5.3496 0.1100 2.10% 5.2396 5.3996 5.2196
Dec 27, 2024 5.3996 0.2300 4.45% 5.1696 5.4696 5.1696
Dec 26, 2024 5.3096 0.1700 3.31% 5.1396 5.4096 5.1396
Dec 24, 2024 5.2196 -0.0700 -1.32% 5.2896 5.4596 5.1396
Dec 23, 2024 5.3496 -0.3400 -5.98% 5.6896 5.6896 5.1396
Dec 20, 2024 5.3996 0.6600 13.93% 4.7396 5.3996 4.6896
Dec 19, 2024 4.8196 0.0600 1.26% 4.7596 4.9196 4.4996
Dec 18, 2024 4.8096 -0.2600 -5.13% 5.0696 5.2196 4.7596

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

DiaMedica Therapeutics Inc. Company profile

About DiaMedica Therapeutics Inc

DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for neurological and kidney diseases, such as acute ischemic stroke (AIS) and chronic kidney disease (CKD). The Company's lead product DM199 mimics the behavior of naturally occurring human KLK1 proteins to preserve and restore circulation to stroke-damaged tissue and improve overall kidney function. KLK1 is a serine protease, or protein, produced primarily in the kidneys, pancreas and salivary glands. DM199 therapy has the potential to improve circulation and overall function of critical systems, as well as reduce inflammation and oxidative stress. The Company also has other product pipelines for IgA Nephropathy and African Americans with CKD.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, DiaMedica Therapeutics Inc revenues was not reported. Net loss increased 11% to $13.6M. Higher net loss reflects General and administrative - Balancing increase of 23% to $3.8M (expense), Research and development - Balancing increase of 7% to $8.3M (expense), Governmental assistance research incen decrease from $205K (income) to $0K.

Industry: Bio Therapeutic Drugs

301 Carlson Parkway
Suite 210
MINNEAPOLIS
MINNESOTA 55305
US

People also watch

ETH/USD

3,294.27 Price
-5.220% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Gold

2,703.08 Price
-0.430% 1D Chg, %
Long position overnight fee 0.0056%
Short position overnight fee -0.0138%
Overnight fee time 22:00 (UTC)
Spread 0.60

BTC/USD

102,841.45 Price
-1.750% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

XRP/USD

3.10 Price
-5.720% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01547

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading